Cover Image

RECURRENT MOLAR PREGNANCY

JAYASHREE B

Abstract


Gestational Trophoblastic Disease (GTD) originates from placental tissue and is among the rare human tumors that can be cured even in the presence of widespread metastases. GTD include a spectrum of interrelated tumors including complete and partial hydatidiform mole, invasive mole, choriocarcinoma, and placental site trophoblastic tumor, that have different propensities for local invasion and spread. Although most GTD develop after a mole, they can follow any antecedent pregnancy.Transvaginal ultrasound, routinary dosage of beta-hCG and current approaches to  chemotherapy, let most women with malignant gestational trophoblastic disease to be cured and their reproductive           function preserved. We present a case of 26 yrs old woman who presented with recurrent molar pregnancy

 


Full Text:

PDF

References


Sebire NJ, Seckl MJ. Gestational trophoblastic disease: Current managementof hydatidiform mole. BMJ.2008;337:452–8. [PubMed]

Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol.2003;17:837–47. [PubMed]

AlMulhim AA. Hydatiform mole. JFCM. 2000;7:57–61. [PMC free article] [PubMed]

Bagshawe KD, Rent J, Webb J. Hydatidiform mole in England and Wales. Lancet. 1986;2:673–7.[PubMed]

Sebire NJ, Foskett RA, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relationship to age. BJOG. 2002;109:99–102. [PubMed]

Pour Reza M, Agheli N, Baghefi SB. Serum creatinine and urea and protein level changes in hydatidiform mole. JAMA. 1974;230:580–1. [PubMed]

Palmer JR, Driscoll SG, Rosenberg L, Berkowitz RS, Lurain JR, Soper J, et al. Oral contraceptive use and risk of gestational trophoblastic tumours. J Natl Cancer Inst. 1999;91:635–40. [PubMed]

Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet. 1999;8 :667–71. [PubMed]

Seckl MJ, Rustin GJ. Late toxicity after therapy for gestational trophoblastic tumours. In: Hancock BW, Newlands ES, Berkowitz RS, Cole LA, editors. Gestational Trophoblastic Disease. 3rd ed. London: International Society for the Study of Trophoblastic Disease; 2003. pp. 470–84.

Rustin GJS, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, et al. Combination but not single agent chemotherapy for gestational trophoblastic tumours (GTT) increases the incidence of seconds tumours. J Clin Oncol. 1996;14:2769–73. [PubMed]


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University